1-deoxynojirimycin has been researched along with Fatty Liver in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, P; Hou, J; Ji, X; Jin, C; Liu, N; Song, Z; Wen, F | 1 |
| Li, C; Li, H; Li, X; Liu, Q; Peng, G; Wang, F; Zheng, Y | 1 |
| Aerts, JM; Aten, J; Bijl, N; Boot, RG; Claessen, N; Groen, AK; Langeveld, M; Moerland, PD; Ottenhoff, R; Sokolović, M; van Eijk, M; van Roomen, CP; Vrins, C | 1 |
| Aerts, JM; Aten, J; Bietrix, FM; Bijl, N; Boot, RG; Dekker, N; Groen, AK; Groener, J; Langeveld, M; Lombardo, E; Ottenhoff, R; Overkleeft, HS; Serlie, M; van Eijk, M; van Roomen, C; Wennekes, T | 1 |
| Aerts, JM; Aten, J; Bietrix, F; Groen, AK; Kuiper, J; Lombardo, E; Ottenhoff, R; Overkleeft, HS; van Eijk, M; van Puijvelde, GH; van Roomen, CP; Verhoeven, AJ | 1 |
1 review(s) available for 1-deoxynojirimycin and Fatty Liver
| Article | Year |
|---|---|
Glycosphingolipids and insulin resistance.
Topics: 1-Deoxynojirimycin; Adamantane; Animals; Cardiovascular Diseases; Ceramides; Diabetes Mellitus, Type 2; Dioxanes; Disease Models, Animal; Fatty Acids; Fatty Liver; Gaucher Disease; Glucosyltransferases; Glycosphingolipids; Humans; Insulin Resistance; Metabolic Syndrome; Mice; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Pyrrolidines; Receptor, Insulin; Signal Transduction | 2011 |
4 other study(ies) available for 1-deoxynojirimycin and Fatty Liver
| Article | Year |
|---|---|
Alleviating effect of mulberry leaf 1-deoxynojirimycin on resistin-induced hepatic steatosis and insulin resistance in mice.
Topics: 1-Deoxynojirimycin; Animals; Fatty Liver; Insulin; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Morus; Plant Leaves; Resistin | 2022 |
1-Deoxynojirimycin Alleviates Liver Injury and Improves Hepatic Glucose Metabolism in db/db Mice.
Topics: 1-Deoxynojirimycin; Animals; Dose-Response Relationship, Drug; Fatty Liver; Glucose; Hypoglycemic Agents; Injections, Intravenous; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Mice, Transgenic; Molecular Structure; Signal Transduction | 2016 |
Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice.
Topics: 1-Deoxynojirimycin; Adamantane; Animals; Disease Models, Animal; Fatty Liver; Glucose; Glycosphingolipids; Homeostasis; Insulin; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Triglycerides | 2009 |
Correction of liver steatosis by a hydrophobic iminosugar modulating glycosphingolipids metabolism.
Topics: 1-Deoxynojirimycin; Actins; Adamantane; Animals; Apolipoprotein E3; Cell Membrane; Diet, High-Fat; Dose-Response Relationship, Drug; Fatty Acids; Fatty Liver; Female; Gene Expression; Glycosphingolipids; Humans; Hydrophobic and Hydrophilic Interactions; Imino Sugars; Immunohistochemistry; Insulin; Lipid Metabolism; Liver; Mice; Mice, Knockout; Mice, Transgenic; Muscle, Smooth; Oxidation-Reduction; Receptors, LDL | 2012 |